Publication | Closed Access

Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer’s disease

Proteomic TechnologyNeurodegenerative DiseasesAlzheimer's DiseaseMedicineWhite MatterDifferential Plasma ProteinsWhite Matter IntegrityBiomarkersPlasma ProteomicsNeurochemical BiomarkersNeurologyNeuroscienceProteomicsHigh Risk